Shanghai MicroPort EV MedTech Co. Ltd. A (688351) - Total Liabilities

Latest as of March 2026: CN¥191.14 Million CNY ≈ $27.97 Million USD

Based on the latest financial reports, Shanghai MicroPort EV MedTech Co. Ltd. A (688351) has total liabilities worth CN¥191.14 Million CNY (≈ $27.97 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Shanghai MicroPort EV MedTech Co. Ltd. A - Total Liabilities Trend (2020–2025)

This chart illustrates how Shanghai MicroPort EV MedTech Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. See 688351 working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Shanghai MicroPort EV MedTech Co. Ltd. A Competitors by Total Liabilities

The table below lists competitors of Shanghai MicroPort EV MedTech Co. Ltd. A ranked by their total liabilities.

Company Country Total Liabilities
Csg Smart Science&Technology Co Ltd
SHE:300222
China CN¥2.83 Billion
nCino Inc
NASDAQ:NCNO
USA $623.38 Million
GIMV NV
BR:GIMB
Belgium €422.95 Million
S&T Bancorp Inc
NASDAQ:STBA
USA $8.51 Billion
Minmetals Development Co Ltd
SHG:600058
China CN¥16.54 Billion
NCAB Group
ST:NCAB
Sweden Skr2.08 Billion
Liberty Global PLC Class C
NASDAQ:LBTYK
USA $12.43 Billion
SRG Global Ltd
AU:SRG
Australia AU$591.77 Million

Liability Composition Analysis (2020–2025)

This chart breaks down Shanghai MicroPort EV MedTech Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Shanghai MicroPort EV MedTech Co. Ltd. A market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 9.82 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.11 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.10 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shanghai MicroPort EV MedTech Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shanghai MicroPort EV MedTech Co. Ltd. A (2020–2025)

The table below shows the annual total liabilities of Shanghai MicroPort EV MedTech Co. Ltd. A from 2020 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥190.96 Million
≈ $27.94 Million
+25.68%
2024-12-31 CN¥151.95 Million
≈ $22.23 Million
+9.94%
2023-12-31 CN¥138.21 Million
≈ $20.22 Million
+18.28%
2022-12-31 CN¥116.85 Million
≈ $17.10 Million
+47.52%
2021-12-31 CN¥79.21 Million
≈ $11.59 Million
+16.96%
2020-12-31 CN¥67.73 Million
≈ $9.91 Million
--

About Shanghai MicroPort EV MedTech Co. Ltd. A

SHG:688351 China Medical Devices
Market Cap
$1.61 Billion
CN¥11.03 Billion CNY
Market Cap Rank
#7085 Global
#1617 in China
Share Price
CN¥23.43
Change (1 day)
+1.78%
52-Week Range
CN¥19.29 - CN¥27.52
All Time High
CN¥28.60
About

Shanghai MicroPort EP MedTech Co., Ltd. engages in the research, development, production, and sale of medical devices in the field of electrophysiological interventional diagnosis and ablation therapy in China and internationally. The company offers cardiac ablation catheters, diagnostic catheters, and system navigational solutions; access conventional solutions; cryoablation solutions; and robot… Read more